Patients with advanced cancer are faced with many devastating symptoms in the last weeks and days of life, such as pain, delirium, dyspnea, bronchial hypersecretions (death rattle) and intractable seizures. Symptom management in the last weeks of life can be particularly challenging because of the high prevalence of delirium complicating symptom assessment, high symptom expression secondary to psychosocial and spiritual factors, limited life-expectancy requiring special considerations for prognosis-based decision-making, and distressed caregivers. There is a paucity of research involving patients in the last weeks of life, contributing to substantial variations in clinical practice. In this narrative review, we shall review the existing literature and provide a practical approach to in-patient management of several of the most distressing physical symptoms in the last weeks to days of life.
Citations
Citations to this article as recorded by
Comparing the use of aggressive end-of life care among frail and non-frail patients with cancer using a claims-based frailty index Rishi Sachdev, Galen Shearn-Nance, Long Vu, Wyatt P. Bensken, Sara L. Douglas, Siran M. Koroukian, Johnie Rose Journal of Geriatric Oncology.2024; 15(2): 101706. CrossRef
Purpose The “Act on Hospice and Palliative Care and Decisions on Life-Sustaining Treatment for Patients at the End-of-Life” was enacted on February 3, 2016 and went into effect on February 4, 2018 in Korea. This study reviewed the first year of determination to life-sustaining treatment (LST) through data analysis of the National Agency for Management of Life-Sustaining Treatment.
Materials and Methods The National Agency for Management of LST provided data between February 4, 2018 and January 31, 2019 anonymously from 33,549 patients. According to the forms patients were defined as either elf-determinants or family-determinants.
Results The median age of the patient was 73 and the majority was male (59.9%). Cancer patients were 59% and self-determinants were 32.1%. Cancer patients had a higher rate of self-determinants than non-cancer (47.3% vs. 10.1%). Plan for hospice service was high in cancer patients among self-determinants (81.0% vs. 37.5%, p < 0.001). In comparison to family-determinants, self-determinants were younger (median age, 67 years vs. 75 years; p < 0.001) and had more cancer diagnosis (87.1% vs. 45.9%, p < 0.001). Decision of withholding or withdrawing of LSTs in cancer patients was higher than non-cancer patients in four items.
Conclusion Cancer patients had a higher rate in self-determination and withholding or withdrawing of LSTs than non-cancer patients. Continued revision of the law and education of the public will be able to promote withdrawing or withholding the futile LSTs in patients at end-of-life. Further study following the revision of the law should be evaluated to change of end-of-life care.
Citations
Citations to this article as recorded by
Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea Yoon Jung Jang, Yun Jung Yang, Hoi Jung Koo, Hye Won Yoon, Seongbeom Uhm, Sun Young Kim, Jeong Eun Kim, Jin Won Huh, Tae Won Kim, Seyoung Seo Cancer Research and Treatment.2025; 57(1): 280. CrossRef
Issues and implications of the life-sustaining treatment decision act: comparing the data from the survey and clinical data of inpatients at the end-of-life process Eunjeong Song, Dongsoon Shin, Jooseon Lee, Seonyoung Yun, Minjeong Eom, Suhee Oh, Heejung Lee, Jiwan Lee, Rhayun Song BMC Medical Ethics.2024;[Epub] CrossRef
Recent Trends in the Withdrawal of Life-Sustaining Treatment in Patients with Acute Cerebrovascular Disease : 2017–2021 Seung Hwan Kim, Ji Hwan Jang, Young Zoon Kim, Kyu Hong Kim, Taek Min Nam Journal of Korean Neurosurgical Society.2024; 67(1): 73. CrossRef
Healthcare Utilization and Supportive Care Timing in South Korean People Living With Amyotrophic Lateral Sclerosis: A Single-Center Retrospective Study Min Seol Jang, Shin Hye Yoo, Min Sun Kim, Belong Cho, Kyae Hyung Kim, Jeongmi Shin, Inyoung Hwang, Seok-Jin Choi, Jung-Joon Sung, Sun Young Lee Journal of Clinical Neurology.2024; 20(2): 166. CrossRef
Differences in end-of-life care patterns between types of hospice used for cancer patients: a retrospective cohort study Il Yun, Eun-Cheol Park, Chung Mo Nam, Jaeyong Shin, Suk-Yong Jang, Sung-In Jang BMC Palliative Care.2024;[Epub] CrossRef
Validation of the Korean Version of the Clinical Frailty Scale-Adjusted Korean Triage and Acuity Scale for Older Patients in the Emergency Department Ho Sub Chung, Yunhyung Choi, Ji Yeon Lim, Keon Kim, Sung Jin Bae, Yoon Hee Choi, Dong Hoon Lee Medicina.2024; 60(6): 955. CrossRef
Beyond Legal Boundaries: Public and Clinician Perspectives on Treatment Withdrawal in Infants With Poor Neurological Prognosis In Gyu Song, Jung Lee, Min Sun Kim, Ji Weon Lee, So Yeon Jeon, Shin Hye Yoo, Hye Yoon Park Journal of Korean Medical Science.2024;[Epub] CrossRef
Preferred versus Actual Place of Care and Factors Associated with Home Discharge among Korean Patients with Advanced Cancer: A Retrospective Cohort Study In Young Hwang, Yohan Han, Min Sun Kim, Kyae Hyung Kim, Belong Cho, Wonho Choi, Yejin Kim, Shin Hye Yoo, Sun Young Lee Healthcare.2023; 11(13): 1939. CrossRef
Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in Korea Ae-Rin Baek, Sang-Bum Hong, Soohyun Bae, Hye Kyeong Park, Changhwan Kim, Hyun-Kyung Lee, Woo Hyun Cho, Jin Hyoung Kim, Youjin Chang, Heung Bum Lee, Hyun-Il Gil, Beomsu Shin, Kwang Ha Yoo, Jae Young Moon, Jee Youn Oh, Kyung Hoon Min, Kyeongman Jeon, Moon S BMC Medical Ethics.2023;[Epub] CrossRef
Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement Dae Seog Heo, Shin Hye Yoo, Bhumsuk Keam, Sang Ho Yoo, Younsuck Koh The Korean Journal of Hospice and Palliative Care.2022; 25(1): 1. CrossRef
Hospice-Palliative Medicine as a Model of Value-Based Healthcare Dae Seog Heo, Shin Hye Yoo, Bhumsuk Keam, Keunjoo Yoo, Insun Choi, Min-Jeong Kim Journal of Korean Medical Science.2022;[Epub] CrossRef
Will implementation of the Life-sustaining Treatment Decisions Act reduce the incidence of cardiopulmonary resuscitation? In-Ae Song Acute and Critical Care.2022; 37(2): 256. CrossRef
Aggressiveness of care in the last days of life in the emergency department of a tertiary hospital in Korea Jung Sun Kim, Sun Young Lee, Min Sung Lee, Shin Hye Yoo, Jeongmi Shin, Wonho Choi, Yejin Kim, Hyung Sook Han, Jinui Hong, Bhumsuk Keam, Dae Seog Heo BMC Palliative Care.2022;[Epub] CrossRef
Hospice Care Preferences and Its Associated Factors among Community-Dwelling Residents in China Huijing Lin, Eunjeong Ko, Bei Wu, Ping Ni International Journal of Environmental Research and Public Health.2022; 19(15): 9197. CrossRef
Impact of COVID-19 on the End-of-Life Care of Cancer Patients Who Died in a Korean Tertiary Hospital: A Retrospective Study Jeongmi Shin, Yejin Kim, Shin Hye Yoo, Jin-Ah Sim, Bhumsuk Keam The Korean Journal of Hospice and Palliative Care.2022; 25(4): 150. CrossRef
The Law Changes Behaviors: Is It Just Enough? Dae Ho Lee Cancer Research and Treatment.2021; 53(4): 895. CrossRef
Purpose This cross-sectional study investigated the status of life-sustaining treatment (LST) practices and identified characteristics and factors influencing decision-making practices.
Materials and Methods The National Agency for Management of Life-sustaining Treatment retains records provided by doctors regarding patients subject to LST implementation. A total of 71,327 patients receiving LST were identified. We analyzed all nationally reported data between February 2018 and October 2019. Indicators such as the proportion of deaths, records for decision to terminate LST, implementation of LST records, and registration of Advance Statements on LST were analyzed.
Results A total of 67,252 (94.3%) end-of life decisions were implemented in South Korea. The proportion of deaths preceded by a LST plan, non-self-determination LST decision, and any advance statements was 33.5% (23,891/71,327), 66.5% (47,436/71,327), and 1.2% (890/71,327), respectively. The logistic regression model revealed that self-determination to terminate LST was more frequent for men than for women and higher for those aged 30-69. Disability (odds ratio [OR], 0.59; 95% confidence interval [CI], 0.56 to 0.61), living in non-metropolitan areas (OR, 0.84; 95% CI, 0.81 to 0.86), and disease comorbidity was independently associated with a low level of self-determination.
Conclusion After the implementation of the new LST Act, about a third of patients in end-of-life process made decisions regarding their medical LST. However, family members still play a major role in LST decisions where the patient’s intention cannot be verified. Decisions related to LST are predominantly made when death is imminent. Thus, it is necessary to increase awareness of end-of-life LST decision-making among medical staff and the public.
Citations
Citations to this article as recorded by
Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea Yoon Jung Jang, Yun Jung Yang, Hoi Jung Koo, Hye Won Yoon, Seongbeom Uhm, Sun Young Kim, Jeong Eun Kim, Jin Won Huh, Tae Won Kim, Seyoung Seo Cancer Research and Treatment.2025; 57(1): 280. CrossRef
Characteristics of Life-Sustaining Treatment Decisions: National Data Analysis in South Korea Jiyeon Choi, Heejung Jeon, Ilhak Lee Asian Bioethics Review.2024; 16(1): 33. CrossRef
Recent Trends in the Withdrawal of Life-Sustaining Treatment in Patients with Acute Cerebrovascular Disease : 2017–2021 Seung Hwan Kim, Ji Hwan Jang, Young Zoon Kim, Kyu Hong Kim, Taek Min Nam Journal of Korean Neurosurgical Society.2024; 67(1): 73. CrossRef
The Impact of Withdrawing or Withholding of Life-Sustaining Treatment: A Nationwide Case-Control Study Based on Medical Cost Analysis Claire Junga Kim, Do-Kyong Kim, Sookyeong Mun, Minkook Son Journal of Korean Medical Science.2024;[Epub] CrossRef
Characteristics and outcomes of patients with do-not-resuscitate and physician orders for life-sustaining treatment in a medical intensive care unit: a retrospective cohort study Song-I Lee, Ye-Rin Ju, Da Hyun Kang, Jeong Eun Lee BMC Palliative Care.2024;[Epub] CrossRef
Clinical Characteristics and Prognosis of Older Patients with Coronavirus Disease 2019 Requiring Mechanical Ventilation Green Hong, Da Hyun Kang, Sunghoon Park, Su Hwan Lee, Onyu Park, Taehwa Kim, Hye Ju Yeo, Jin Ho Jang, Woo Hyun Cho, Song I Lee Journal of Personalized Medicine.2024; 14(6): 657. CrossRef
Comparison of factors influencing the decision to withdraw life-sustaining treatment in intensive care unit patients after implementation of the Life-Sustaining Treatment Act in Korea Claire Junga Kim, Kyung Sook Hong, Sooyoung Cho, Jin Park Acute and Critical Care.2024; 39(2): 294. CrossRef
Validation of the Korean Version of the Clinical Frailty Scale-Adjusted Korean Triage and Acuity Scale for Older Patients in the Emergency Department Ho Sub Chung, Yunhyung Choi, Ji Yeon Lim, Keon Kim, Sung Jin Bae, Yoon Hee Choi, Dong Hoon Lee Medicina.2024; 60(6): 955. CrossRef
Psychosocial Factors Associated With Thoughts Regarding Life-Sustaining Treatment for Oneself and Family Members Jeewon Lee, Shin-Gyeom Kim, Soyoung Irene Lee, HyunChul Youn Psychiatry Investigation.2024; 21(6): 646. CrossRef
Emergency department and intensive care unit health professionals' knowledge and application of the law that applies to end-of-life decision-making for adults: A scoping review of the literature Jayne Hewitt, Nemat Alsaba, Katya May, Halima Sadia Noon, Cooper Rennie, Andrea P. Marshall Australian Critical Care.2023; 36(4): 628. CrossRef
Decision and Practice of End-of-Life Care in Lung Disease Patients with Physicians Orders for Life Sustaining Treatment Yu Mi Oh, Yoon Na Kang, Soo Jung Han, Jeong Hye Kim The Korean Journal of Hospice and Palliative Care.2023; 26(1): 7. CrossRef
Advance Care Planning in South Korea Yu Jung Kim, Sun-Hyun Kim Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68. CrossRef
Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms Jae Eun Jang, Jeong Moon Ryu, Min Hee Heo, Do Eun Kwon, Ji Yeon Seo, Dong Yeon Kim The Korean Journal of Hospice and Palliative Care.2023; 26(2): 69. CrossRef
Comparison of the end-of-life decisions of patients with hospital-acquired pneumonia after the enforcement of the life-sustaining treatment decision act in Korea Ae-Rin Baek, Sang-Bum Hong, Soohyun Bae, Hye Kyeong Park, Changhwan Kim, Hyun-Kyung Lee, Woo Hyun Cho, Jin Hyoung Kim, Youjin Chang, Heung Bum Lee, Hyun-Il Gil, Beomsu Shin, Kwang Ha Yoo, Jae Young Moon, Jee Youn Oh, Kyung Hoon Min, Kyeongman Jeon, Moon S BMC Medical Ethics.2023;[Epub] CrossRef
Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea Dalyong Kim, Shin Hye Yoo, Seyoung Seo, Hyun Jung Lee, Min Sun Kim, Sung Joon Shin, Chi-Yeon Lim, Do Yeun Kim, Dae Seog Heo, Chae-Man Lim Cancer Research and Treatment.2022; 54(1): 20. CrossRef
Problems Related to the Act on Decisions on Life-Sustaining Treatment and Directions for Improvement Dae Seog Heo, Shin Hye Yoo, Bhumsuk Keam, Sang Ho Yoo, Younsuck Koh The Korean Journal of Hospice and Palliative Care.2022; 25(1): 1. CrossRef
Derivation and performance of an end-of-life practice score aimed at interpreting worldwide treatment-limiting decisions in the critically ill Spyros D. Mentzelopoulos, Su Chen, Joseph L. Nates, Jacqueline M. Kruser, Christiane Hartog, Andrej Michalsen, Nikolaos Efstathiou, Gavin M. Joynt, Suzana Lobo, Alexander Avidan, Charles L. Sprung, Wesley Ely, Erwin J. O. Kompanje, Mervyn Mer, Charles Fel Critical Care.2022;[Epub] CrossRef
Will implementation of the Life-sustaining Treatment Decisions Act reduce the incidence of cardiopulmonary resuscitation? In-Ae Song Acute and Critical Care.2022; 37(2): 256. CrossRef
The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017–2018 Jinsoo Min, Hyung Woo Kim, Helen R. Stagg, Molebogeng X. Rangaka, Marc Lipman, Ibrahim Abubakar, Yunhee Lee, Jun-Pyo Myong, Hyunsuk Jeong, Sanghyuk Bae, Ah Young Shin, Ji Young Kang, Sung-Soon Lee, Jae Seuk Park, Hyeon Woo Yim, Ju Sang Kim Frontiers in Medicine.2022;[Epub] CrossRef
Preparation and Practice of the Necessary Documents in Hospital for the “Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life” Sun Kyung Baek, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Young-Woong Won, Yu Jung Kim, Sujin Baik, Hyewon Ryu Cancer Research and Treatment.2021; 53(4): 926. CrossRef
Purpose In Korea, hospice palliative care (HPC) provision for cancer patients has increased recently. However, whether end of life (EoL) care practices have improved along with the development of HPC is unclear. We intended to investigate the changes in EoL care practices and their association with HPC referral. Materials and Methods Retrospective medical record review of adult cancer patients who died at National Cancer Center Korea from 1 January 2009 to 31 December 2014 was performed. Changes of EoL practices including chemotherapy within 2 weeks from death, death in intensive care unit (ICU), documentation of “do not resuscitate (DNR)” within 7 days from death and referral to HPC from 2009 to 2014 were analyzed as well as the association between referral to HPC and other practices.
Results A total of 2,377 cases were included in the analysis. Between 2009 and 2014, referral to HPC increased and DNR documentation within 7 days from death decreased significantly. Cases for chemotherapy within 2 weeks from death and death in ICU didn’t change over the study period. Patients referred to HPC were less likely to receive chemotherapy within 2 weeks from death, die in ICU and document DNR within 7 days from death. Conclusion During the study period, EoL practices among cancer patients partly changed toward less aggressive in our institution. HPC referral was associated with less aggressive cancer care at the EoL. Policies to promote EoL discussion are necessary to improve the EoL practices of cancer patients.
Citations
Citations to this article as recorded by
Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: a nationwide study from 2012 to 2018 Sara Kwon, Kyuwoong Kim, Bohyun Park, So-Jung Park, Hyun Jung Jho, Jin Young Choi BMC Palliative Care.2024;[Epub] CrossRef
Symptom burden, palliative care knowledge, and palliative care needs in advanced gynecological cancer patients in Korea Eungil Ko, Yaelim Lee Supportive Care in Cancer.2024;[Epub] CrossRef
End-of-Life Decision Making in Patients with Advanced Dementia: The Perspectives of the Korean General Population and Clinicians So Yeon Jeon, Shin Hye Yoo, Jung Lee, In Gyu Song, Min Sun Kim, Hye Yoon Park Psychiatry Investigation.2024; 21(10): 1137. CrossRef
Advance Care Planning in South Korea Yu Jung Kim, Sun-Hyun Kim Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68. CrossRef
Public awareness of advance care planning and hospice palliative care: a nationwide cross-sectional study in Korea Boram Kim, Junyong Lee, Youn Seon Choi BMC Palliative Care.2023;[Epub] CrossRef
Prevalence and related factors of do-not-resuscitate orders among in-hospital cardiac arrest patients Tangxing Jiang, Yanyan Ma, Jiaqi Zheng, Chunyi Wang, Kai Cheng, Chuanbao Li, Feng Xu, Yuguo Chen Heart & Lung.2022; 51: 9. CrossRef
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, Hyun Ae Jung, Hee Kyung Ahn, Kyung Hee Lee, Min-ho Kim, Ju Hee Kim, Jaekyung Cheon, Su-Jin Koh Supportive Care in Cancer.2022; 30(9): 7431. CrossRef
A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making? So-Youn Park, Bomyee Lee, Jeong Yeon Seon, In-Hwan Oh Cancer Research and Treatment.2021; 53(2): 593. CrossRef
Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study Shin Hye Yoo, Wonho Choi, Yejin Kim, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo Cancer Research and Treatment.2021; 53(2): 584. CrossRef
Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act Hyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, Young Joo Min, Jae-Cheol Jo, Yunsuk Choi, Yoo Jin Lee, Daseul Kang, Changyoung Kim, Su-Jin Koh, Jaekyung Cheon BMC Palliative Care.2021;[Epub] CrossRef
Consent for withholding life-sustaining treatment in cancer patients: a retrospective comparative analysis before and after the enforcement of the Life Extension Medical Decision law Yu Jin Chung, Incheol Park, Junho Cho, Jin Ho Beom, Ji Eun Lee BMC Medical Ethics.2021;[Epub] CrossRef
Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo Cancer Research and Treatment.2020; 52(3): 917. CrossRef
Purpose
The aims of this study were to investigate trends of aggressive treatment of non-small cell lung cancer (NSCLC) patients at the end-of-life (EOL) during the recent 5 years and examine the relationship between hospice consultation (HC) and aggressive care.
Materials and Methods
The medical records of 789 patients with stage IIIB-IV NSCLC at Seoul National University Hospital (SNUH) who received palliative chemotherapy and died from 2010 to 2014 were retrospectively reviewed. Indicators of aggressive treatment were evaluated, and the association of HC with these indicators was analyzed.
Results
During the last 5 years, the frequency of HC increased from 26.7% to 43.6%. The time interval from last chemotherapy to death increased, and the proportion of patients who received palliative chemotherapy, visited an emergency room, were admitted to intensive care unit, during the last month of life, and died in SNUH significantly decreased over time. Referral to HC was significantly associated with lower intensive care unit admission rates, lower out-of-hospital death rates, and less use of the chemotherapy within 1 month prior to death. Overall survival did not differ by HC.
Conclusion
The pattern of cancer care nearthe EOL has become less aggressivewhen HCwas provided. The positive association of HCwith better EOL care suggests that providing HC at the optimal time might help to avoid futile aggressive treatment.
Citations
Citations to this article as recorded by
Hospice delivery models and survival differences in the terminally ill: a large cohort study Wei-Shu Lai, I-Ting Liu, Jui-Hung Tsai, Pei-Fang Su, Pin-Hsuan Chiu, Ying-Tzu Huang, Ge-Lin Chiu, Yu-Yeh Chen, Peng-Chan Lin BMJ Supportive & Palliative Care.2024; 14(e1): e1134. CrossRef
Use of high‐flow nasal cannula oxygen therapy for patients with terminal cancer at the end of life Jung Sun Kim, Jeongmi Shin, Nam Hee Kim, Sun Young Lee, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo Cancer Medicine.2023; 12(13): 14612. CrossRef
Antibiotic prescription patterns during last days of hospitalized patients with advanced cancer: the role of palliative care consultation Jeong-Han Kim, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo Journal of Antimicrobial Chemotherapy.2023; 78(7): 1694. CrossRef
Discussing POLST-facilitated hospice care enrollment in patients with terminal cancer Ho Jung An, Hyun Jeong Jeon, Sang Hoon Chun, Hyun Ae Jung, Hee Kyung Ahn, Kyung Hee Lee, Min-ho Kim, Ju Hee Kim, Jaekyung Cheon, Su-Jin Koh Supportive Care in Cancer.2022; 30(9): 7431. CrossRef
Perceptions on the current content and pedagogical approaches used in end-of-life care education among undergraduate nursing students: a qualitative, descriptive study Wenjing Cao, Chunyan Li, Qianqian Zhang, Huiru Tong BMC Medical Education.2022;[Epub] CrossRef
Increased in-hospital mortality and emergent cases in patients with stage IV cancer Elleana J. Majdinasab, Yana Puckett, Kevin Y. Pei Supportive Care in Cancer.2021; 29(6): 3201. CrossRef
Changes of End of Life Practices for Cancer Patients and Their Association with Hospice Palliative Care Referral over 2009-2014: A Single Institution Study Hyun Jung Jho, Eun Jung Nam, Il Won Shin, Sun Young Kim Cancer Research and Treatment.2020; 52(2): 419. CrossRef
Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo Cancer Research and Treatment.2020; 52(3): 917. CrossRef
Do advance directive attitudes and perceived susceptibility and end-of-life life-sustaining treatment preferences between patients with heart failure and cancer differ? JinShil Kim, Jiin Choi, Mi-Seung Shin, Miyeong Kim, EunJu Seo, Minjeong An, Jae Lan Shim, Seongkum Heo, Hans-Peter Brunner-La Rocca PLOS ONE.2020; 15(9): e0238567. CrossRef
Duration of palliative care before death in international routine practice: a systematic review and meta-analysis Roberta I. Jordan, Matthew J. Allsop, Yousuf ElMokhallalati, Catriona E. Jackson, Helen L. Edwards, Emma J. Chapman, Luc Deliens, Michael I. Bennett BMC Medicine.2020;[Epub] CrossRef
Relationship Between Preferences for Advance Directive Treatments and Decisional Conflicts Among Low-Income, Home-Based Cancer Management Recipients in Korea Miyeong Kim, Seongkum Heo, Jung-Yi Hur, JaeLan Shim, JinShil Kim Journal of Transcultural Nursing.2019; 30(6): 587. CrossRef
Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study Amanda J.W. Gibson, Haocheng Li, Adrijana D’Silva, Anifat A. Elegbede, Roxana A. Tudor, Shannon Otsuka, D. Gwyn Bebb, Winson Y. Cheung Lung Cancer.2019; 134: 141. CrossRef
Interventions to reduce aggressive care at end of life among patients with cancer: a systematic review Nauzley C Abedini, Rachel K Hechtman, Achintya D Singh, Rafina Khateeb, Jason Mann, Whitney Townsend, Vineet Chopra The Lancet Oncology.2019; 20(11): e627. CrossRef
Demographic and Socioeconomic Factors for Renouncing Further Active Therapy for Patients with Brain Metastasis of Non-Small Cell Lung Cancer Gyuseo Jung, Seok-Hyun Kim, Tae Gyu Kim, Young Zoon Kim Brain Tumor Research and Treatment.2019; 7(2): 112. CrossRef
Purpose
We explored the relationship between the use of each medical intervention and the length of time between do-not-resuscitate (DNR) consent and death in Korea.
Materials and Methods
A total of 295 terminal cancer patients participated in this retrospective study. Invasive interventions (e.g., cardiopulmonary resuscitation, intubation, and hemodialysis), less invasive interventions (e.g., transfusion, antibiotic use, inotropic use, and laboratory tests), and the time interval between the DNR order and death were evaluated. The subjects were divided into three groups based on the amount of time between DNR consent and death (G1, time interval ≤ 1 day; G2, time interval > 1 day to ≤ 3 days; and G3, time interval > 3 days).
Results
In general, there were fewer transfusions and laboratory tests near death. Invasive interventions tended to be implemented only in the G1 group. There was also less inotrope use and fewerlaboratory tests in the G3 group than G1 and G2. Moreover, the G3 group received fewer less invasive interventions than those in G1 (odds ratio [OR], 0.16; 95% confidence interval [CI], 0.03 to 0.84; 3 days before death, and OR, 0.16; 95% CI, 0.04 to 0.59; the day before death). The frequency of less invasive interventions both 1 and 3 days before death was significantly lower for the G3 group than the G1 (p ≤ 0.001) and G2 group compared to G1 (p=0.001).
Conclusion
Earlier attainment of DNR permission was associated with reduced use of medical intervention. Thus, physicians should discuss death with terminal cancer patients at the earliest practical time to prevent unnecessary and uncomfortable procedures and reduce health care costs.
Citations
Citations to this article as recorded by
Truth-telling, and ethical considerations in terminal care: an Eastern perspective Qing Ma, Yi Wu, Ronghua Fang Nursing Ethics.2025;[Epub] CrossRef
Current trends in antimicrobial use and the role of antimicrobial stewardship in palliative oncology: a narrative review Bassem Awada, Aref Zribi, Ahmad Al Ghoche, Souha S. Kanj BMC Palliative Care.2025;[Epub] CrossRef
Antibiotic Use at the End of Life: Current Practice and Ways to Optimize Minji Kang, Winnie S. Wang, Zieanna Chang American Journal of Hospice and Palliative Medicine®.2024;[Epub] CrossRef
Participation and Influencing Factors in the Decision-Making of Life-Sustaining Treatment: A Focus on Deceased Patients with Hematologic Neoplasms Jae Eun Jang, Jeong Moon Ryu, Min Hee Heo, Do Eun Kwon, Ji Yeon Seo, Dong Yeon Kim The Korean Journal of Hospice and Palliative Care.2023; 26(2): 69. CrossRef
Advance Care Planning in South Korea Yu Jung Kim, Sun-Hyun Kim Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen.2023; 180: 68. CrossRef
“Do not resuscitate” order and end‐of‐life treatment in a cohort of deceased in a Norwegian University Hospital Hans F. L. van der Werff, Torstein H. Michelet, Olav M. Fredheim, Siri Steine Acta Anaesthesiologica Scandinavica.2022; 66(8): 1009. CrossRef
Factors influencing terminal cancer patients’ autonomous DNR decision: a longitudinal statutory document and clinical database study Ru-Yih Chen, Ying-Chun Li, Kuang-Chieh Hsueh, Fu-Wei Wang, Hong-Jhe Chen, Tzu-Ya Huang BMC Palliative Care.2022;[Epub] CrossRef
Antibiotic use during end-of-life care: A systematic literature review and meta-analysis Alexandre R. Marra, Mireia Puig-Asensio, Erin Balkenende, Daniel J. Livorsi, Michihiko Goto, Eli N. Perencevich Infection Control & Hospital Epidemiology.2021; 42(5): 523. CrossRef
An observational study on the effects of delayed initiation of end-of-life care in terminally ill young adults in the intensive care unit AnirbanHom Choudhuri, Sakshi Duggal, Bhuvna Ahuja, Rajeev Uppal Indian Journal of Palliative Care.2021; 27(1): 31. CrossRef
Code status at time of rapid response activation — Impact on escalation of care? Alexandra Erath, Kipp Shipley, Louisa Anne Walker, Erin Burrell, Liza Weavind Resuscitation Plus.2021; 6: 100102. CrossRef
A National Study of Life-Sustaining Treatments in South Korea: What Factors Affect Decision-Making? So-Youn Park, Bomyee Lee, Jeong Yeon Seon, In-Hwan Oh Cancer Research and Treatment.2021; 53(2): 593. CrossRef
Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study Shin Hye Yoo, Wonho Choi, Yejin Kim, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo Cancer Research and Treatment.2021; 53(2): 584. CrossRef
Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act Hyeyeong Kim, Hyeon-Su Im, Kyong Og Lee, Young Joo Min, Jae-Cheol Jo, Yunsuk Choi, Yoo Jin Lee, Daseul Kang, Changyoung Kim, Su-Jin Koh, Jaekyung Cheon BMC Palliative Care.2021;[Epub] CrossRef
The Magnitude and Effects of Early Integration of Palliative Care Into Oncology Service Among Adult Advanced Cancer Patients at a Tertiary Care Hospital Elham H Ghabashi, Belal M Sharaf, Waheed A Kalaktawi, Retaj Calacattawi, Abdullah W Calacattawi Cureus.2021;[Epub] CrossRef
Can primary palliative care education change life-sustaining treatment intensity of older adults at the end of life? A retrospective study Qian Liu, Mingzhao Qin, Jian Zhou, Hui Zheng, Weiping Liu, Qi Shen BMC Palliative Care.2021;[Epub] CrossRef
Analysis of high-intensity care in intensive care units and its cost at the end of life among older people in South Korea between 2016 and 2019: a cross-sectional study of the health insurance review and assessment service national patient sample database Yunji Lee, Minjeong Jo, Taehwa Kim, Kyoungsun Yun BMJ Open.2021; 11(8): e049711. CrossRef
Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life Young-Woong Won, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Sun Kyung Baek, Yu Jung Kim, Do Yeun Kim, Hyewon Ryu Cancer Research and Treatment.2021; 53(4): 908. CrossRef
Preparation and Practice of the Necessary Documents in Hospital for the “Act on Decision of Life-Sustaining Treatment for Patients at the End-of-Life” Sun Kyung Baek, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Young-Woong Won, Yu Jung Kim, Sujin Baik, Hyewon Ryu Cancer Research and Treatment.2021; 53(4): 926. CrossRef
Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo Cancer Research and Treatment.2020; 52(3): 917. CrossRef
Evaluating if an Advance Care Planning Intervention Promotes Do-Not-Resuscitate Orders by Facilitating Accurate Prognostic Awareness Fur-Hsing Wen, Chen Hsiu Chen, Wen-Chi Chou, Jen-Shi Chen, Wen-Cheng Chang, Chia-Hsun Hsieh, Siew Tzuh Tang Journal of the National Comprehensive Cancer Network.2020; 18(12): 1658. CrossRef
The Characteristics of Patients in the Actively Dying Phase by Documenting the Implementation of Decisions on Life-sustaining Treatment Jean Shin, Chung-Woo Lee, Youn Seon Choi, Seon Mee Kim, Hong-Seok Park, Seok-Won Park, Eunshik Mo, Jaehyun Park, Hyunjin Lee, Sungyoon Joung Korean Journal of Clinical Geriatrics.2020; 21(2): 103. CrossRef
Cuidados en los últimos días de vida en los pacientes hospitalizados en medicina interna J. Díez-Manglano, S. Isasi de Isasmendi Pérez, M. Rubio Gómez, F. Formiga, L.Á. Sánchez Muñoz, J. Castiella Herrero, E. Casariego Vales, O.H. Torres Bonafonte, Jesús Díez-Manglano, Soledad Isasi de Isasmendi Pérez, Marta Rubio Gómez, Magdalena Martín Pére Revista Clínica Española.2019; 219(3): 107. CrossRef
End-of-life care for patients hospitalized in internal medicine departments J. Díez-Manglano, S. Isasi de Isasmendi Pérez, M. Rubio Gómez, F. Formiga, L.Á. Sánchez Muñoz, J. Castiella Herrero, E. Casariego Vales, O.H. Torres Bonafonte Revista Clínica Española (English Edition).2019; 219(3): 107. CrossRef
Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act Hye Yoon Park, Young Ae Kim, Jin-Ah Sim, Jihye Lee, Hyewon Ryu, Jung Lim Lee, Chi Hoon Maeng, Jung Hye Kwon, Yu Jung Kim, Eun Mi Nam, Hyun-Jeong Shim, Eun-Kee Song, Kyung Hae Jung, Eun Joo Kang, Jung Hun Kang, Young Ho Yun Journal of Pain and Symptom Management.2019; 57(4): 774. CrossRef
Completion rate of physician orders for life-sustaining treatment for patients with metastatic or recurrent cancer: a preliminary, cross-sectional study Ju Won Kim, Jung Yoon Choi, Won Jin Jang, Yoon Ji Choi, Youn Seon Choi, Sang Won Shin, Yeul Hong Kim, Kyong Hwa Park BMC Palliative Care.2019;[Epub] CrossRef
Receipt of Vasopressors Is Positively Associated With the Length of the Actively Dying Process in Hospitalization Hsiao-Chen Chou, Hsien-Liang Huang, Chiang-Yi Chen, Chuan-Lan Wang, Chin-Chung Shu, Nin-Chieh Hsu, Yu-Feng Lin, Jin-Shing Chen, Wang-Huei Sheng American Journal of Hospice and Palliative Medicine®.2018; 35(8): 1043. CrossRef
The NEAT Predictive Model for Survival in Patients with Advanced Cancer Amanda Zucker, Chiaojung Jillian Tsai, John Loscalzo, Pedro Calves, Johnny Kao Cancer Research and Treatment.2018; 50(4): 1433. CrossRef
The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo Cancer Research and Treatment.2018; 50(3): 720. CrossRef
Comparison of Life-Sustaining Treatment in Terminal Cancer Patients between a Cancer and Hospice Unit after Do-Not-Resuscitate Orders Eun Jeong Nam, Se-Na Lee, Ran Lee Asian Oncology Nursing.2018; 18(4): 198. CrossRef
Purpose The purpose of this study was to evaluate the cancer care cost during the last year of life of patients in Korea. Materials and Methods We studied the breakdown of spending on the components of cancer care. Cancer decedents in 2009 were identified from the Korean Central Cancer Registry and linked with the Korean National Health Insurance Claims Database. The final number of patients included in the study was 70,558.
Results In 2009, the average cancer care cost during the last year of life was US $15,720. Patients under age 20 spent US $53,890 while those 70 or over spent US $11,801. Those with leukemia incurred the highest costs (US $43,219) while bladder cancer patients spent the least (US $13,155). General costs, drugs other than analgesics, and test fees were relatively high (29.7%, 23.8%, and 20.7% of total medical costs, respectively). Analgesic drugs, rehabilitation, and psychotherapy were still relatively low (4.3%, 0.7%, and 0.1%, respectively). Among the results of multiple regression analysis, few were notable. Age was found to be negatively related to cancer care costs while income level was positively associated. Those classified under distant Surveillance, Epidemiology, and End Results stages of cancer and higher comorbidity level also incurred higher cancer care costs. Conclusion Average cancer care costs varied significantly by patient characteristics. However, the study results suggest an underutilization of support services likely due to lack of alternative accommodations for terminal cancer patients. Further examination of utilization patterns of healthcare resources will help provide tailored evidence for policymakers in efforts to reduce the burdens of cancer care.
Citations
Citations to this article as recorded by
Patterns of Medical Utilization in Children, Adolescents, and Young Adults With Life-Limiting Conditions in Korea: A Cohort Study Based on National Health Insurance Data Seonhwa Lee, Byungmi Kim, Jin Young Choi, So-Jung Park, Jun Ah Lee, Chung Ho Kim, Bomi Park, Bohyun Park Journal of Korean Medical Science.2025;[Epub] CrossRef
Medical care costs at the end of life among older adults with cancer: a national health insurance data-based cohort study Minjeong Jo, Yunji Lee, Taehwa Kim BMC Palliative Care.2023;[Epub] CrossRef
Medical cost of advanced illnesses in the last-year of life—retrospective database study Palvinder Kaur, Huei Yaw Wu, Allyn Hum, Bee Hoon Heng, Woan Shin Tan Age and Ageing.2022;[Epub] CrossRef
Projecting Lifetime Health Outcomes and Costs Associated with the Ambient Fine Particulate Matter Exposure among Adult Women in Korea Gyeyoung Choi, Yujeong Kim, Gyeongseon Shin, SeungJin Bae International Journal of Environmental Research and Public Health.2022; 19(5): 2494. CrossRef
Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care Kyu-Tae Han, Woorim Kim, Seungju Kim BMC Cancer.2022;[Epub] CrossRef
Healthcare resource utilization and medical costs in patients with terminal cancer during best supportive care Dong-Won Kang, Yoon-Bo Shim, Eui-Kyung Lee, Mi-Hai Park, Wen-Chi Chou PLOS ONE.2022; 17(6): e0269565. CrossRef
Trends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study Yun-Sok Ha, So-Young Kim, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Ji Youl Lee, Dong Jin Park, Hyun Tae Kim, Eun Sang Yoo, Tae Gyun Kwon, Kyungchan Min, Wun-Jae Kim, Seok Joong Yun, Jo The World Journal of Men's Health.2021; 39(1): 158. CrossRef
End-of-life cost trajectories and the trade-off between treatment costs and life-extension: Findings from the Cost and Medical Care of Patients with Advanced Serious Illness (COMPASS) cohort study Brett Doble, Wei Han Melvin Wong, Eric Finkelstein Palliative Medicine.2021; 35(5): 893. CrossRef
Evolution of health care utilization and expenditure during the year before death in 2015 among people with cancer: French snds-based cohort study Audrey Tanguy-Melac, Dorian Verboux, Laurence Pestel, Anne Fagot-Campagna, Philippe Tuppin, Christelle Gastaldi-Ménager The European Journal of Health Economics.2021; 22(7): 1039. CrossRef
How the resource allocation and inpatient behavior affect the expenditures of terminal malignant tumor patients? Fen Li, Bifan Zhu, Peimin Sang, Chunlin Jin Journal of Cancer Policy.2020; 25: 100249. CrossRef
Cost of Care and Pattern of Medical Care Use in the Last Year of Life among Long-Term Care Insurance Beneficiaries in South Korea: Using National Claims Data Sunjoo Boo, Jungah Lee, Hyunjin Oh International Journal of Environmental Research and Public Health.2020; 17(23): 9078. CrossRef
The Last Year Before Graft Failure Negatively Impacts Economic Outcomes and is Associated With Greater Healthcare Resource Utilization Compared With Previous Years in the United Kingdom: Results of a Retrospective Observational Study Gorden Muduma, Varuna Aluvihare, Marc Clancy, Enrico de Nigris, Carolyn Whitlock, Margarita Landeira, Jameel Nazir Transplantation Direct.2019; 5(5): e443. CrossRef
National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database Ho Won Kang, Seok-Joong Yun, Jae Il Chung, Hoon Choi, Jae Heon Kim, Ho Song Yu, Yun-Sok Ha, In-Chang Cho, Hyung Joon Kim, Hyun Chul Chung, Jun Sung Koh, Wun-Jae Kim, Jong-Hyock Park, Ji Youl Lee, So-Young Kim BMC Health Services Research.2019;[Epub] CrossRef
Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany M.P. Lux, N. Nabieva, T. Hildebrandt, H. Rebscher, S. Kümmel, J.-U. Blohmer, M.G. Schrauder The Breast.2018; 37: 89. CrossRef
Intensity of Care at the End of Life Among Older Adults in Korea Su Hyun Kim, Sangwook Kang, Mi-Kyung Song Journal of Palliative Care.2018; 33(1): 47. CrossRef
Gasto en el último año de vida para pacientes que mueren con cáncer Sergio I. Prada, Juan F. Contreras Revista Colombiana de Cancerología.2018; 22(1): 3. CrossRef
Medical care costs of cancer in the last year of life using national health insurance data in Korea Mihai Park, Inmyung Song, M Barton Laws PLOS ONE.2018; 13(6): e0197891. CrossRef
The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo Cancer Research and Treatment.2018; 50(3): 720. CrossRef
Evaluation of the Cost of Comprehensive Outpatient Therapies in Patients with Malignant Brain Tumors Stacy McCarty, Susan Keeshin, Sarah M. Eickmeyer, Samman Shahpar, Patrick Semik, Alex W. K. Wong American Journal of Physical Medicine & Rehabilitation.2017; 96(5): 341. CrossRef
Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada Ahmed S. Zakaria, Fabiano Santos, Alice Dragomir, Wassim Kassouf, Simon Tanguay, Armen Aprikian Urologic Oncology: Seminars and Original Investigations.2017; 35(9): 539.e1. CrossRef
Joint Symposium of Korean Cancer Association & UICC-ARO—Cross-boundary cancer studies: cancer and Universal Health Coverage (UHC) in Asia Eun-Cheol Park, Norie Kawahara, Shinjiro Nozaki, Hasbullah Thabrany, Shunya Yoshimi, Sohee Park, Duk Hyoung Lee, Hideyuki Akaza, Jae Kyung Roh Japanese Journal of Clinical Oncology.2017; 47(9): 889. CrossRef
Escalating Health Care Expenditures in Cancer Decedents’ Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan Yen-Ni Hung, Tsang-Wu Liu, Fur-Hsing Wen, Wen-Chi Chou, Siew Tzuh Tang The Oncologist.2017; 22(4): 460. CrossRef
Purpose The purpose of this study was to investigate and compare cancer treatment near the end-of-life (EOL) over a 10-year period. Materials and Methods Patients with advanced solid cancer at Seoul National University Hospital who received palliative chemotherapy and had died were enrolled. We categorized the consecutive patients according to two time periods: 2002 (n=57) and 2012 (n=206). Aggressiveness of cancer treatment near the EOL was evaluated.
Results The median patient age was 62, and 65.4% of patients (n=172) were male. Time from the last chemotherapy to death (TCD) was found to have been significantly shortened, from 66.0 days to 34.0 days during 10 years (p < 0.001); 17% of patients received molecular targeted agents as the last chemotherapy regimen in 2012. The proportion of patients who received intensive care unit care within the last month increased from 1.8% in 2002 to 19.9% in 2012 (p < 0.001), and emergency room visits within the last month also increased from 22.8% to 74.8% (p < 0.001). Although hospice referral increased from 9.1% to 37.4% (p < 0.001), timing of referral was delayed from median 53 days to 8 days before death (p=0.004). Use of targeted agents as the last chemotherapy for over-two-regimen users was associated with shortened TCD (hazard ratio, 2.564; p=0.002). Conclusion Cancer treatment near the EOL became more aggressive over 10 years.
Citations
Citations to this article as recorded by
Factors Affecting Life-Sustaining Treatment Decisions and Changes in Clinical Practice after Enforcement of the Life-Sustaining Treatment (LST) Decision Act: A Tertiary Hospital Experience in Korea Yoon Jung Jang, Yun Jung Yang, Hoi Jung Koo, Hye Won Yoon, Seongbeom Uhm, Sun Young Kim, Jeong Eun Kim, Jin Won Huh, Tae Won Kim, Seyoung Seo Cancer Research and Treatment.2025; 57(1): 280. CrossRef
Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: a nationwide study from 2012 to 2018 Sara Kwon, Kyuwoong Kim, Bohyun Park, So-Jung Park, Hyun Jung Jho, Jin Young Choi BMC Palliative Care.2024;[Epub] CrossRef
Patients’ Trajectory With Lung Cancer From Treatment Initiation to End-Of-Life: A Retrospective Cohort Study Using Claims Data in Japan Yuri Ogura, Masahiro Iwasaku, Mami Ishida, Yuki Katayama, Naoya Nishioka, Kenji Morimoto, Chie Yamamoto, Shinsaku Tokuda, Yoshiko Kaneko, Tadaaki Yamada, Hideya Yamazaki, Masayoshi Inoue, Hiroshi Ikai, Koichi Takayama Cancer Control.2024;[Epub] CrossRef
The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study Jeong-Han Kim, Shin Hye Yoo, Bhumsuk Keam, Dae Seog Heo Journal of Antimicrobial Chemotherapy.2023; 78(1): 302. CrossRef
Trends in appropriateness of end-of-life care in people with cancer, COPD or with dementia measured with population-level quality indicators Robrecht De Schreye, Luc Deliens, Lieven Annemans, Birgit Gielen, Tinne Smets, Joachim Cohen, Lihua Li PLOS ONE.2023; 18(2): e0273997. CrossRef
Quality of End-of-Life Care during the COVID-19 Pandemic at a Comprehensive Cancer Center Yvonne Heung, Donna Zhukovsky, David Hui, Zhanni Lu, Clark Andersen, Eduardo Bruera Cancers.2023; 15(8): 2201. CrossRef
Cancer care patterns in South Korea: Types of hospital where patients receive care and outcomes using national health insurance claims data Dong‐Woo Choi, Sun Jung Kim, Seungju Kim, Dong Wook Kim, Wonjeong Jeong, Kyu‐Tae Han Cancer Medicine.2023; 12(13): 14707. CrossRef
Frequency of anticancer drug use at the end of life: a scoping review Endre Szigethy, Rosario Dorantes, Miguel Sugrañes, Meisser Madera, Ivan Sola, Gerard Urrútia, Xavier Bonfill Clinical and Translational Oncology.2023; 26(1): 178. CrossRef
Preferred versus Actual Place of Care and Factors Associated with Home Discharge among Korean Patients with Advanced Cancer: A Retrospective Cohort Study In Young Hwang, Yohan Han, Min Sun Kim, Kyae Hyung Kim, Belong Cho, Wonho Choi, Yejin Kim, Shin Hye Yoo, Sun Young Lee Healthcare.2023; 11(13): 1939. CrossRef
Effectiveness of Palliative Care before Death in Reducing Emergency Care Utilization for Patients with Terminal Cancer and Trends in the Utilization of Palliative Care from 2005–2018 Yi-Shiun Tsai, Wen-Chen Tsai, Li-Ting Chiu, Pei-Tseng Kung Healthcare.2023; 11(21): 2907. CrossRef
Potentially inappropriate end-of-life care and its association with relatives’ well-being: a systematic review Laurien Ham, Ellis Slotman, Carolien Burghout, Natasja JH Raijmakers, Lonneke V van de Poll-Franse, Lia van Zuylen, Heidi P Fransen Supportive Care in Cancer.2023;[Epub] CrossRef
Disparities in healthcare expenditures according to economic status in cancer patients undergoing end-of-life care Kyu-Tae Han, Woorim Kim, Seungju Kim BMC Cancer.2022;[Epub] CrossRef
Reasons for chemotherapy discontinuation and end-of-life in patients with gastrointestinal cancer: A multicenter prospective AGEO study Lola-Jade Palmieri, Olivier Dubreuil, Jean-Baptiste Bachet, Isabelle Trouilloud, Christophe Locher, Romain Coriat, Frederick Moryoussef, Bruno Landi, Géraldine Perkins, Vincent Hautefeuille, Solène Doat Clinics and Research in Hepatology and Gastroenterology.2021; 45(1): 101431. CrossRef
Effect of Treatment with the PD-1/PD-L1 Inhibitors on Key Health Outcomes of Cancer Patients Kyung-In Joung, Jong Hwa Song, Kangho Suh, Seung-Mi Lee, Ji Hyun Jun, Taehwan Park, Dong Churl Suh BioDrugs.2021; 35(1): 61. CrossRef
Difficulties Doctors Experience during Life-Sustaining Treatment Discussion after Enactment of the Life-Sustaining Treatment Decisions Act: A Cross-Sectional Study Shin Hye Yoo, Wonho Choi, Yejin Kim, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo Cancer Research and Treatment.2021; 53(2): 584. CrossRef
Life-Sustaining Treatment States in Korean Cancer Patients after Enforcement of Act on Decisions on Life-Sustaining Treatment for Patients at the End of Life Young-Woong Won, Hwa Jung Kim, Jung Hye Kwon, Ha Yeon Lee, Sun Kyung Baek, Yu Jung Kim, Do Yeun Kim, Hyewon Ryu Cancer Research and Treatment.2021; 53(4): 908. CrossRef
Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer Renée. S. J. M. Schmitz, Sandra. M. E. Geurts, Khava. I. E. Ibragimova, Dominique. J. P. Tilli, Vivianne. C. G. Tjan-Heijnen, Maaike de Boer Cancers.2021; 13(21): 5271. CrossRef
Impact of Palliative Care on Quality of End-of-Life Care Among Brazilian Patients With Advanced Cancers Talita Caroline de Oliveira Valentino, Carlos Eduardo Paiva, David Hui, Marco Antonio de Oliveira, Bianca Sakamoto Ribeiro Paiva Journal of Pain and Symptom Management.2020; 59(1): 39. CrossRef
Aggressive End-of-Life Care and Symptom Relief Treatments in Terminally Ill Patients Who Had Discussed Withdrawal of Mechanical Ventilation: A Hospital-Based Observational Study Hsiao-Ting Chang, Ming-Hwai Lin, Chun-Ku Chen, Tzeng-Ji Chen, Shinn-Jang Hwang American Journal of Hospice and Palliative Medicine®.2020; 37(11): 897. CrossRef
Chemotherapy and Tyrosine Kinase Inhibitors in the last month of life in patients with metastatic lung cancer: A patient file study in the Netherlands Adinda Mieras, Annemarie Becker‐Commissaris, H. Roeline W. Pasman, Anne‐Marie M. C. Dingemans, Edith V. Kok, Robin Cornelissen, Wouter Jacobs, Jan Willem Berg, Alle Welling, Brigitte A. H. A. Bogaarts, Lemke Pronk, Bregje D. Onwuteaka‐Philipsen European Journal of Cancer Care.2020;[Epub] CrossRef
Modifiable Factors Associated with the Completion of Advance Treatment Directives in Hematologic Malignancy: A Patient–Caregiver Dyadic Analysis JinShil Kim, Jinny Park, Mee Ok Lee, Eun Young Park, Seongkum Heo, Jae Lan Shim Journal of Palliative Medicine.2020; 23(5): 611. CrossRef
Changes of End of Life Practices for Cancer Patients and Their Association with Hospice Palliative Care Referral over 2009-2014: A Single Institution Study Hyun Jung Jho, Eun Jung Nam, Il Won Shin, Sun Young Kim Cancer Research and Treatment.2020; 52(2): 419. CrossRef
Adverse events in deceased hospitalised cancer patients as a measure of quality and safety in end-of-life cancer care Ellinor Christin Haukland, Christian von Plessen, Carsten Nieder, Barthold Vonen BMC Palliative Care.2020;[Epub] CrossRef
Implication of the Life-Sustaining Treatment Decisions Act on End-of-Life Care for Korean Terminal Patients Jung Sun Kim, Shin Hye Yoo, Wonho Choi, Yejin Kim, Jinui Hong, Min Sun Kim, Hye Yoon Park, Bhumsuk Keam, Dae Seog Heo Cancer Research and Treatment.2020; 52(3): 917. CrossRef
Status and cost analysis of antimicrobial treatment of terminally ill patients with hematological malignancy in an acute hospital Miyuki Chiba, Miyako Negishi, Sanae Miyagawa, Satoru Suzuki, Emiko Sasai, Kazunori Sugai, Shotaro Hagiwara Journal of Infection and Chemotherapy.2020; 26(12): 1288. CrossRef
Factors associated with the aggressiveness of care at the end of life for patients with cancer dying in hospital: a nationwide retrospective cohort study in mainland Portugal Diogo Martins-Branco, Silvia Lopes, Rita Canario, Joao Freire, Madalena Feio, Jose Ferraz-Goncalves, Gabriela Sousa, Nuno Lunet, Barbara Gomes ESMO Open.2020; 5(6): e000953. CrossRef
Duration of palliative care before death in international routine practice: a systematic review and meta-analysis Roberta I. Jordan, Matthew J. Allsop, Yousuf ElMokhallalati, Catriona E. Jackson, Helen L. Edwards, Emma J. Chapman, Luc Deliens, Michael I. Bennett BMC Medicine.2020;[Epub] CrossRef
Attitudes of the General Public, Cancer Patients, Family Caregivers, and Physicians Toward Advance Care Planning: A Nationwide Survey Before the Enforcement of the Life-Sustaining Treatment Decision-Making Act Hye Yoon Park, Young Ae Kim, Jin-Ah Sim, Jihye Lee, Hyewon Ryu, Jung Lim Lee, Chi Hoon Maeng, Jung Hye Kwon, Yu Jung Kim, Eun Mi Nam, Hyun-Jeong Shim, Eun-Kee Song, Kyung Hae Jung, Eun Joo Kang, Jung Hun Kang, Young Ho Yun Journal of Pain and Symptom Management.2019; 57(4): 774. CrossRef
Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002-2015 Soo Min Jeon, Jin-Won Kwon, Sun Ha Choi, Hae-Young Park, Seil Sohn PLOS ONE.2019; 14(2): e0212878. CrossRef
The Korean–Advance Directive Model and Factors Associated With Its Completion Among Patients With Hematologic Disorders Mee Ok Lee, Jinny Park, Eun Young Park, Youngji Kim, Eunjoo Bang, Seongkum Heo, JinShil Kim Journal of Hospice & Palliative Nursing.2019; 21(4): E10. CrossRef
Are physicians on the same page about do-not-resuscitate? To examine individual physicians’ influence on do-not-resuscitate decision-making: a retrospective and observational study Yen-Yuan Chen, Melany Su, Shu-Chien Huang, Tzong-Shinn Chu, Ming-Tsan Lin, Yu-Chun Chiu, Kuan-Han Lin BMC Medical Ethics.2019;[Epub] CrossRef
Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care Olivier Bylicki, Morgane Didier, Frederic Riviere, Jacques Margery, Frederic Grassin, Christos Chouaid BMJ Supportive & Palliative Care.2019; 9(4): 413. CrossRef
Correlates of life-support treatment preferences among low-income home-based cancer management recipients JinShil Kim, Seongkum Heo, Mi Yeong Kim, Eun Young Park, Eun Ju Seo, Mee Ok Lee, Bo Yoon Jeong, Jung-Ah Lee European Journal of Oncology Nursing.2019; 43: 101665. CrossRef
Determinants of Last-line Treatment in Metastatic Breast Cancer Marika Cinausero, Lorenzo Gerratana, Elisa De Carlo, Donatella Iacono, Marta Bonotto, Valentina Fanotto, Vanessa Buoro, Debora Basile, Maria Grazia Vitale, Karim Rihawi, Gianpiero Fasola, Fabio Puglisi Clinical Breast Cancer.2018; 18(3): 205. CrossRef
Impact of Targeted Therapy on the Quality of End-of-Life Care for Patients With Non–Small-Cell Lung Cancer: A Population-Based Study in Taiwan Hsin-Yun Tsai, Kuo-Piao Chung, Raymond Nien-Chen Kuo Journal of Pain and Symptom Management.2018; 55(3): 798. CrossRef
Outpatient Palliative Care and Aggressiveness of End-of-Life Care in Patients with Metastatic Colorectal Cancer Si Won Lee, Hyun Jung Jho, Ji Yeon Baek, Eun Kyung Shim, Hyun Mi Kim, Ji Yeon Ku, Eun Jung Nam, Yoon-Jung Chang, Hye Jin Choi, Sun Young Kim American Journal of Hospice and Palliative Medicine®.2018; 35(1): 166. CrossRef
Differences in do-not-resuscitate orders, hospice care utilization, and late referral to hospice care between cancer and non-cancer decedents in a tertiary Hospital in Taiwan between 2010 and 2015: a hospital-based observational study Tzu-Chien Shih, Hsiao-Ting Chang, Ming-Hwai Lin, Chun-Ku Chen, Tzeng-Ji Chen, Shinn-Jang Hwang BMC Palliative Care.2018;[Epub] CrossRef
Factors Associated with Early Referral to Palliative Care in Outpatients with Advanced Cancer Deepa Wadhwa, Gordana Popovic, Ashley Pope, Nadia Swami, Lisa W. Le, Camilla Zimmermann Journal of Palliative Medicine.2018; 21(9): 1322. CrossRef
Qualitative study of patients’ decision-making when accepting second-line treatment after failure of first-line chemotherapy Jean-Louis Pujol, Benoît Roch, Caroline Roth, Jean-Pierre Mérel, Yvonne Drewes PLOS ONE.2018; 13(5): e0197605. CrossRef
The Disease Burden of Lung Cancer Attributable to Residential Radon Exposure in Korean Homes Jong-Hun Kim, Mina Ha Journal of Korean Medical Science.2018;[Epub] CrossRef
The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo Cancer Research and Treatment.2018; 50(3): 720. CrossRef
End-of-life care decisions using a Korean advance directive among cancer patient–caregiver dyads Shinmi Kim, Sujin Koh, Kwonoh Park, Jinshil Kim Palliative and Supportive Care.2017; 15(1): 77. CrossRef
Long-term survival of out-of-hospital cardiac arrest patients with malignancy Saee Byel Kang, Kyung Su Kim, Gil Joon Suh, Woon Yong Kwon, Kyoung Min You, Min Ji Park, Jung-In Ko, Taegyun Kim The American Journal of Emergency Medicine.2017; 35(10): 1457. CrossRef
Palliative care consultants’ ethical concerns with advanced cancer patients participating in phase 1 clinical trials. A case study Nunziata Comoretto, Ana Larumbe, Maria Arantzamendi, Carlos Centeno Progress in Palliative Care.2017; 25(5): 230. CrossRef
Cases and Literature Review of Timing for Withdrawal of Palliative Chemotherapy Yun Jin Jeong, Do Yeun Kim The Korean Journal of Hospice and Palliative Care.2016; 19(1): 70. CrossRef
Intensive care unit prognostic factors in critically ill patients with advanced solid tumors: a 3-year retrospective study Rui Xia, Donghao Wang BMC Cancer.2016;[Epub] CrossRef
Herausforderungen der palliativen onkologischen Chirurgie Konrad K. Richter, U. Wedding Der Onkologe.2015; 21(11): 1074. CrossRef